Stanford Health Care / Stanford Cancer Institute
Stanford is home to CAR-T innovation (Mackall, Majzner), the CD47 discovery (Weissman), and AI in medicine.
GD2 CAR-T for DIPG, CD47/magrolimab origins, Stanford Medicine AI, CyberKnife invention (Adler), lymphoma leadership (Levy).
- CAR-T for paediatric brain tumours
- AI in oncology
- Lymphoma
Co-invented the CAPP-Seq method for reading tumour DNA in blood and used it to track lymphoma and lung cancer.
Crystal Mackall is a cell therapy pioneer whose team brought GD2 CAR-T to children with lethal brain tumours.
Heather Wakelee is a lung cancer leader who led the first adjuvant immunotherapy trial to change practice.
Isolated the first blood stem cells and discovered the 'don't eat me' signal CD47 on cancer cells.
Radiation oncologist who showed a blood test can detect leftover lung cancer months before scans.
Developed the first antibody treatment for cancer, rituximab, and still works on training the immune system against lymphoma.
Steven Artandi is a telomerase biologist who directs Stanford's cancer institute.
Pages like this
not linked directly; found by shared links- InstitutionArc Institute
Shares Evo 2 (Arc Institute, NVIDIA), Chan Zuckerberg Biohub, Virtual cell roadmap: from bulk omics to a predictive model of a cancer cell.
- TermH3 K27M (diffuse midline glioma)
Shares Crystal L. Mackall, CAR-T for glioma (IL13Rα2, GD2, EGFRvIII, multi-target), The brain: barrier and sanctuary, Glioma & glioblastoma.
- TechnologyArmoured, logic-gated & next-gen CARs
Shares Crystal L. Mackall, CAR-T for glioma (IL13Rα2, GD2, EGFRvIII, multi-target), Neuroblastoma (paediatric), Glioma & glioblastoma.
- InstitutionMemorial Sloan Kettering Cancer Center
Shares Damon Runyon Cancer Research Foundation, Cut the nerve supply to tumours with old drugs, Is aneuploidy itself a druggable vulnerability?, Cancer neuroscience (nerve–tumour signalling).
- InstitutionUCSF Helen Diller Family Comprehensive Cancer Center
Shares Emerson Collective, Damon Runyon Cancer Research Foundation, Chan Zuckerberg Biohub.
- CompanyChan Zuckerberg Initiative (Biohub)
Shares Universal Cell Embedding (UCE), Virtual cell roadmap: from bulk omics to a predictive model of a cancer cell.
- PathwayThe blood–brain barrier & brain metastasis
Shares Cancer neuroscience (nerve–tumour signalling), CAR-T for glioma (IL13Rα2, GD2, EGFRvIII, multi-target), The brain: barrier and sanctuary, SBRT / SABR (stereotactic radiotherapy).
- PathwayClonal evolution & minimal residual disease
Shares Attack extrachromosomal DNA, the engine of oncogene amplification, Kill drug-tolerant persisters through ferroptosis, Chromosomal instability & aneuploidy, Cancer stem cells & phenotypic plasticity.